Literature DB >> 16094650

Inhibitory effect of linoleic acid on transformation of IEC6 intestinal cells by in vitro azoxymethane treatment.

Takamitsu Sasaki1, Kazuhiro Yoshida, Hideo Shimura, Masayosi Ichiba, Tomonori Sasahira, Takasumi Shimomoto, Ayumi Denda, Hiroki Kuniyasu.   

Abstract

The effect of linoleic acid (LA) on growth and transformation of IEC6 intestinal cells was examined. IEC6 cells expressed mRNAs of 15-lipooxygenase (LOX15) and peroxisome proliferator-activated receptor (PPAR)gamma but not COX-2. Cell growth was suppressed by LA in a dose-dependent manner in IEC6 cells. Three-week treatment with LA provided IEC6 cells a quiescent state. LA-induced growth inhibition was abrogated by exposure to antisense S-oligodeoxynucleotides (S-ODNs) for LOX15 and/or PPARgamma. In an in vitro carcinogenesis model, IEC6 cells, which had confirmed CYP2E1 expression and activity, were continuously treated with AOM and/or LA for 40 weeks. DNA injury in AOM-treated cells was suppressed to the control level by concurrent LA treatment. Colony formation of AOM-treated cells in soft agar was suppressed by treatment with LA, which was reversed by exposure to antisense S-ODNs for LOX15 and/or PPARgamma. AOM-treated IEC6 cells formed s.c. tumors in 9 of 12 mice, whereas AOM+LA-treated cells formed no tumor. IEC6 cells showed no remarkable alteration of protein production by AOM treatment, whereas cells treated with AOM+LA showed decreased epidermal growth factor receptor (EGFR) and phospho-EGFR and increased BAX. These findings suggest that LA inhibited AOM-induced transformation of COX-2-negative IEC6 cells, which was possibly mediated with PPARgamma ligands generated by LOX15 from LA. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16094650     DOI: 10.1002/ijc.21393

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  Co-treatment with deoxycholic acid and azoxymethane accelerates secretion of HMGB1 in IEC6 intestinal epithelial cells.

Authors:  K Fujii; Y Luo; T Sasahira; A Denda; H Ohmori; H Kuniyasu
Journal:  Cell Prolif       Date:  2009-07-06       Impact factor: 6.831

Review 2.  Peroxisome proliferator-activated receptor gamma (PPARgamma) and colorectal carcinogenesis.

Authors:  Ioannis A Voutsadakis
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-21       Impact factor: 4.553

3.  Novel dual cyclooxygenase and lipoxygenase inhibitors targeting hyaluronan-CD44v6 pathway and inducing cytotoxicity in colon cancer cells.

Authors:  Suniti Misra; Shibnath Ghatak; Neha Patil; Prasad Dandawate; Vinita Ambike; Shreelekha Adsule; Deepak Unni; K Venkateswara Swamy; Subhash Padhye
Journal:  Bioorg Med Chem       Date:  2013-02-27       Impact factor: 3.641

4.  The Roles of Dietary PPARgamma Ligands for Metastasis in Colorectal Cancer.

Authors:  Hiroki Kuniyasu
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

5.  PPARgamma: The Portrait of a Target Ally to Cancer Chemopreventive Agents.

Authors:  Ioannis Sainis; Katerina Vareli; Vasilios Karavasilis; Evangelos Briasoulis
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.